Questions and answers (Q&A) on regulatory matters related to the introduction and pharmacovigilance of vaccines against COVID-19. 19 January 2021
Washington, D.C.; PAHO; 2021-02-01. (PAHO/IMS/HSS/MT/COVID-19/21-0001).
en En
| PAHOIRIS
| ID: phr-53229
Biblioteca responsable:
US1.1
ABSTRACT
This document provides answers to the most frequently asked questions related to regulatory mechanisms for the approval and post-monitoring approval of COVID-19 vaccines as well as relevant information on the COVAX Facility requirements related to vaccine eligibility. It also summarizes additional guidance on emergency use authorization processes, WHO emergency use listing procedure applied to COVID-19 vaccines, and the role of regulatory authorities during post-approval monitoring of COVID-19 vaccines.
Texto completo:
1
Colección:
04-international_org
Base de datos:
PAHOIRIS
Asunto principal:
Vacunas
/
Coronavirus
/
Betacoronavirus
/
Acceso a Medicamentos Esenciales y Tecnologías Sanitarias
/
COVID-19
/
Servicios de Salud
Aspecto:
Determinantes_sociais_saude
Idioma:
En
Año:
2021